These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 23830844

  • 1. The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD).
    O'Flaherty D, Sankaralingam A, Scully P, Manghat P, Goldsmith D, Hampson G.
    Clin Biochem; 2013 Oct; 46(15):1405-9. PubMed ID: 23830844
    [Abstract] [Full Text] [Related]

  • 2. Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.
    Tomida K, Hamano T, Mikami S, Fujii N, Okada N, Matsui I, Nagasawa Y, Moriyama T, Ito T, Imai E, Isaka Y, Rakugi H.
    Bone; 2009 Apr; 44(4):678-83. PubMed ID: 19111635
    [Abstract] [Full Text] [Related]

  • 3. Clinical evaluation of two novel biointact PTH(1-84) assays in hemodialysis patients.
    Hecking M, Kainz A, Bielesz B, Plischke M, Beilhack G, Hörl WH, Sunder-Plassmann G, Bieglmayer C.
    Clin Biochem; 2012 Dec; 45(18):1645-51. PubMed ID: 23217247
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease.
    Chen H, Cui Y, Xing C, Purrunsing Y, Zha X, Shen C, Zeng M, Yang G, Yu X, Zhang L, Jiang Y, Shen Z, Ma H, Yin C, Li Y, Wang N.
    Int Urol Nephrol; 2018 Dec; 50(12):2279-2288. PubMed ID: 30361964
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tartrate-resistant acid phosphatase isoform 5a as an inflammation marker in end-stage renal disease.
    Janckila AJ, Lederer ED, Price BA, Yam LT.
    Clin Nephrol; 2009 Apr; 71(4):387-96. PubMed ID: 19356371
    [Abstract] [Full Text] [Related]

  • 10. Relationship between biochemical markers and radial cortical bone changes in hemodialysis patients.
    Fujimori A, Okada S, Sakai M, Tome K, Fukagawa M.
    Nephron Clin Pract; 2011 Apr; 118(4):c375-9. PubMed ID: 21325869
    [Abstract] [Full Text] [Related]

  • 11. Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD).
    Manghat P, Souleimanova I, Cheung J, Wierzbicki AS, Harrington DJ, Shearer MJ, Chowienczyk P, Fogelman I, Nerlander M, Goldsmith D, Hampson G.
    Bone; 2011 May 01; 48(5):1127-32. PubMed ID: 21281749
    [Abstract] [Full Text] [Related]

  • 12. Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis?
    Avbersek-Luznik I, Balon BP, Rus I, Marc J.
    Nephrol Dial Transplant; 2005 Mar 01; 20(3):566-70. PubMed ID: 15665031
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis].
    Nowak Z, Konieczna M, Wańkowicz Z.
    Pol Merkur Lekarski; 2004 Aug 01; 17(98):138-41. PubMed ID: 15603322
    [Abstract] [Full Text] [Related]

  • 15. Intravenous vitamin D therapy reduces PTH-(1-84)/large C fragments ratio in chronic hemodialysis patients.
    Kihara T, Ichikawa H, Morimoto H, Yano A, Akagi S, Nakao K, Kohmoto H, Wada J, Kumagai I, Makino H.
    Nephron Clin Pract; 2004 Aug 01; 98(3):c93-100. PubMed ID: 15528944
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
    Yamada S, Inaba M, Kurajoh M, Shidara K, Imanishi Y, Ishimura E, Nishizawa Y.
    Clin Endocrinol (Oxf); 2008 Aug 01; 69(2):189-96. PubMed ID: 18221403
    [Abstract] [Full Text] [Related]

  • 18. Association between phosphate removal and markers of bone turnover in haemodialysis patients.
    Albalate M, de la Piedra C, Fernández C, Lefort M, Santana H, Hernando P, Hernández J, Caramelo C.
    Nephrol Dial Transplant; 2006 Jun 01; 21(6):1626-32. PubMed ID: 16490746
    [Abstract] [Full Text] [Related]

  • 19. The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
    Yamada S, Tsuruya K, Yoshida H, Taniguchi M, Haruyama N, Tanaka S, Eriguchi M, Nakano T, Kitazono T.
    Clin Endocrinol (Oxf); 2013 Jun 01; 78(6):844-51. PubMed ID: 23078546
    [Abstract] [Full Text] [Related]

  • 20. Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers
.
    Lima F, Mawad H, El-Husseini AA, Davenport DL, Malluche HH.
    Clin Nephrol; 2019 Apr 01; 91(4):222-230. PubMed ID: 30862350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.